Adenine

Papers

The Calcimimetic AMG 641 Abrogates Parathyroid Hyperplasia, Bone And Vascular Calcification Abnormalities In Uremic Rats. Henley, C., et al. Eur. J. Oral Sci. 616, 306-13, (2009)

---

EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling. A.M. DeHaan et al Prostate 69, 528-37, (2009)

---

Identifying Chelators for Metalloprotein Inhibitors Using a Fragment-Based Approach J. A. Jacobsen, et al., J. Med. Chem. 54, 591-602, (2011)

---

Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors. Stefan A Laufer et al J. Med. Chem. 48, 710-22, (2005)

---

The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors. Jung-Feng Hsieh et al Bioorg. Med. Chem. 15, 3450-6, (2007)

---

Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Naomi L Kruhlak et al Toxicol. Mech. Methods 18, 217-27, (2008)

---

Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperone. Paul A Brough et al J. Med. Chem. 52, 4794-809, (2009)

---

Identification of critical ligand binding determinants in Mycobacterium tuberculosis adenosine-5'-phosphosulfate reductase. Jiyoung A Hong et al J. Med. Chem. 52, 5485-95, (2009)

---

Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family. Thomas Borrmann et al J. Med. Chem. 52, 5974-89, (2009)

---

Inhibition of CTP synthase from Escherichia coli by xanthines and uric acids. Alexander C Roy et al Bioorg. Med. Chem. Lett. 20, 141-4, (2010)

---

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Denis Fourches et al Chem. Res. Toxicol. 23, 171-83, (2010)

---

Selectivity of kinase inhibitor fragments. Paul Bamborough et al J. Med. Chem. 54, 5131-43, (2011)

---

Merck 14,152

Beil. 26,IV,3561

Aldrich MSDS 1, 36:A / Corp MSDS 1 (1), 66:D / FT-IR 1 (2), 713:C / FT-IR 2 (3), 3675:A / IR-Spectra (2), 1123:D / IR-Spectra (3), 1291:A / NMR-Reference 2 (2), 589:C / RegBook 1 (2), 2469:L / Sax 6, 138 / Sigma FT-IR 1 (1), 963:B / Structure Index 1, 390:C:7